Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/1346-8138.17194 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diagnostic approach for post-COVID-19 mucormycosis.
Minerva Dent Oral Sci
September 2025
Department of Dental Research Cell, Dr. D.Y. Patil Dental College and Hospital, Dr. D.Y. Patil Vidyapeeth, Pune, India.
The COVID-19 pandemic, particularly in India, continues to pose a major threat to public health owing to the large number of patients that remain affected. The second wave of COVID-19 has brought with it several opportunistic diseases caused by bacteria and fungi, including mucormycosis, which is a well-known fungal infection primarily encountered in immunocompromised individuals through inhalation. In recent times, mucormycosis has become increasingly common in COVID-19 patients, particularly those with comorbidities such as diabetes, and has been observed to induce secondary infections as it spreads with COVID-19 treatment.
View Article and Find Full Text PDFLate-Induced Autoimmune Disorders Post-COVID-19 Vaccination/Infection: Case Report From Iran.
Case Rep Med
August 2025
Clinical Research Department, Pasteur Institute of Iran, Tehran, Iran.
COVID-19 pandemic led to a fast vaccine design due to the threat of rapid spreading worldwide. Safety profile of the approved vaccines has been achieved mostly through clinical trials. However, some unsolicited adverse events in a longer duration of time have been recorded in addition to the late disorders known as long-COVID, stemming from classical infection.
View Article and Find Full Text PDFExploring the Risk Factors of Rosacea Exacerbation Associated with COVID-19 Infection or Vaccination: A Cross-sectional Study.
Acta Derm Venereol
September 2025
Institute of Photomedicine, Shanghai Skin Disease Hospital, School of Medicine, Tongji University, Shanghai, China.
COVID-19 can affect the skin, with rosacea flare-ups reported after infection or vaccination. This study compared rosacea patients with and without post-COVID-19 exacerbation to identify contributing factors. A customized electronic questionnaire was administered to rosacea patients, gathering COVID-19 infection/vaccination status, demographics, and rosacea features.
View Article and Find Full Text PDFInfluenza vaccine effectiveness over 17 seasons in a large Japanese cohort: Analyses by age, virus type, underlying diseases and seasons before the COVID-19 pandemic.
J Infect Public Health
August 2025
Influenza Study Group of Japan Physicians Association, Tokyo Medical Association, Building 4F, 2-5 Kanda-Surugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Background: As populations age and influenza reemerges post-COVID-19, evaluating vaccine effectiveness (VE) across age groups, comorbidities, virus types, and seasons is increasingly important.
Methods: A prospective multicenter cohort study was conducted annually by the Japan Physicians Association. Outpatients were registered with vaccination status before each influenza season and reported rapid antigen test results afterward.
Hot topics in pediatric infectious diseases: vaccines, molecular diagnosis, and emerging challenges post COVID-19.
Curr Opin Infect Dis
October 2025
Department of Infectious Diseases, St Jude Children's Research Hospital, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.